Table 6 P450s as drug targets
| Currently in clinical practice |
| P450 5A1 (anti-platelet drugs, inhibit thromboxane production) |
| Pictamide |
| Riogrel |
| Ozagrel |
| Furegrelate |
| P450 19A1 (breast and other hormonal cancers) |
| Exemestane |
| Anastrozole |
| Letrozole |
| P450 17A1 (prostate cancer) |
| Abiraterone |
| P450 11B1 (Cushing’s disease) |
| Mifepristone |
| P450 51 (anti-fungal, inhibit fungal P450s) |
| Ketoconazole |
| Fluconazole |
| Itraconazole |
| Vorconazole |
| Posaconazole |
| Isavuconazole |
| Mifepristone |
| Discovery and development programs |
| P450 4A11 (hypertension) |
| P450 11A1 (prostate cancer) |
| P450 11B2 (hypertension) |
| P450 24A1 (increase vitamin D3 levels) |
| P450 26A1 (increase vitamin A levels) |
| P450 26B1 (increase vitamin A levels) |